Compensatory Mutations of Rifampin Resistance Are Associated with Transmission of Multidrug-Resistant Mycobacterium tuberculosis Beijing Genotype Strains in China
- 1 May 2016
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 60 (5) , 2807-2812
Abstract
Mycobacterium tuberculosis can acquire resistance to rifampin (RIF) through mutations in the rpoB gene. This is usually accompanied by a fitness cost, which, however, can be mitigated by secondary mutations in the rpoA or rpoC gene. This study aimed to identify rpoA and rpoC mutations in clinical M. tuberculosis isolates in northern China in order to clarify their role in the transmission of drug-resistant tuberculosis (TB). The study collection included 332 RIF-resistant and 178 RIF-susceptible isolates. The majority of isolates belonged to the Beijing genotype (95.3%, 486/510 isolates), and no mutation was found in rpoA or rpoC of the non-Beijing genotype strains. Among the Beijing genotype strains, 27.8% (89/320) of RIF-resistant isolates harbored nonsynonymous mutations in the rpoA ( n = 6) or rpoC ( n = 83) gene. The proportion of rpoC mutations was significantly higher in new cases ( P = 0.023) and in strains with the rpoB S531L mutation ( P < 0.001). In addition, multidrug-resistant (MDR) strains with rpoC mutations were significantly associated with 24-locus mycobacterial interspersed repetitive-unit–variable-number tandem-repeat clustering ( P = 0.016). In summary, we believe that these findings indirectly suggest an epistatic interaction of particular mutations related to RIF resistance and strain fitness and, consequently, the role of such mutations in the spread of MDR M. tuberculosis strains.Keywords
Funding Information
- Open Project of Beijing Key Laboratory of Capital Medical University (2014NYJH02)
- National Natural Science Foundation of China (81271889, 81541062)
This publication has 26 references indexed in Scilit:
- Drug-Resistant Tuberculosis Transmission and Resistance Amplification within FamiliesEmerging Infectious Diseases, 2012
- Primer3—new capabilities and interfacesNucleic Acids Research, 2012
- National Survey of Drug-Resistant Tuberculosis in ChinaNew England Journal of Medicine, 2012
- Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genesNature Genetics, 2011
- Strain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosisClinical Microbiology and Infection, 2011
- Molecular Detection of Mutations Associated with First- and Second-Line Drug Resistance Compared with Conventional Drug Susceptibility Testing of Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2011
- Transmission of MDR and XDR Tuberculosis in Shanghai, ChinaPLOS ONE, 2009
- Epistasis — the essential role of gene interactions in the structure and evolution of genetic systemsNature Reviews Genetics, 2008
- Proposal for Standardization of Optimized Mycobacterial Interspersed Repetitive Unit-Variable-Number Tandem Repeat Typing ofMycobacterium tuberculosisJournal of Clinical Microbiology, 2006
- Evolution of Drug Resistance in Different Sublineages of Mycobacterium tuberculosis Beijing GenotypeAntimicrobial Agents and Chemotherapy, 2006